Additional tumor necrosis factor (TNF) blocker analysis information - MPR
Links shared publicly online about this topic.
- 1,780total visits
Additional tumor necrosis factor (TNF) blocker analysis information - MPR
empr.com —
The FDA notified healthcare professionals on August 4, 2009 that it had completed its analysis of tumor necrosis factor (TNF) blockers and concluded that there is an increased risk of lymphoma and other cancers associated with the use of these drugs in children and adolescents.
View full resource at empr.com
Tags: Cancer, Lymphoma, Drug, Healthcare, Children's Health, FDA
Most Recently Shared on September 1, 2009 at 3:40 pm By:
MPR News: Additional tumor necrosis factor (TNF) blocker analysis information: The FDA notified healthc.. http://bit.ly/704OW
Advertisement
